Skip to main content

Find Clinical Trials

Home
Conditions
Cystic Fibrosis

Clinical trial condition

Cystic Fibrosis

Explore clinical trials studying Cystic Fibrosis. Study availability and eligibility vary by location and protocol.

1,061 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Cystic Fibrosis trial results

Completed

Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators

NCT01348204

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects

NCT01216046

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: PRA Lenexa, Kansas, United States

View Trial Details

Completed

Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic Fibrosis

NCT01343524

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: SUNY Upstate Medical University Syracuse, New York, United States

View Trial Details

Completed

Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

NCT01460836

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis

NCT00221546

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University Hospital Ghent Ghent, Belgium

View Trial Details

Completed

Cystic Fibrosis and Totally Implantable Vascular Access Devices

NCT00244270

Conditions: Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +11 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

NCT00391976

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis

NCT00546663

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: University of North Carolina Chapel Hill, North Carolina, United States

Children's Hospital and Regional Medical Center Seattle, Washington, United States

Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis

NCT00531531

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Cystic Fibrosis Center of Tuscany, Meyer Hospital Florence, Italy

View Trial Details

Completed

Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)

NCT00670579

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Cystic Fibrosis Center of Tuscany, Meyer Hospital Florence, Tuscany, Italy

View Trial Details